What is the loading dose for Keppra (levetiracetam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levetiracetam (Keppra) Loading Dose Recommendations

For status epilepticus in adults, the recommended loading dose for Keppra (levetiracetam) is 30-60 mg/kg IV (maximum 4500 mg), administered at a rate of 100 mg/min. 1

Adult Loading Dose Recommendations

  • The typical fixed loading dose in adults ranges from 1500-3000 mg IV 1
  • The administration rate should not exceed 100 mg/min to minimize adverse effects 1
  • For benzodiazepine-refractory status epilepticus, loading doses ranging from 20-60 mg/kg are used, with higher doses not showing increased efficacy but potentially leading to higher intubation rates 2

Pediatric Loading Dose Recommendations

  • For status epilepticus in children, a loading dose of 20-30 mg/kg IV (maximum 1000 mg per dose) is recommended 1
  • For non-convulsive status epilepticus in children, a higher loading dose of 40 mg/kg (maximum 2,500 mg) IV bolus may be used 1
  • For neonates with status epilepticus, a lower loading dose of 10 mg/kg IV is recommended 1
  • The recommended infusion time is 10-20 minutes in pediatric patients 1

Clinical Considerations

  • Levetiracetam is considered a second-line agent after benzodiazepines for status epilepticus 1
  • Unlike phenytoin/fosphenytoin, levetiracetam does not require cardiac monitoring during administration, making it advantageous in critical care settings 1, 3
  • Levetiracetam has minimal drug interactions, making it suitable for patients on multiple medications 1
  • In ICU settings, levetiracetam has been shown to be effective with 93% of patients having no subsequent seizures after treatment 3

Efficacy and Safety

  • A recent study comparing different loading doses (≤20 mg/kg, 21-39 mg/kg, and ≥40 mg/kg) found no significant difference in seizure termination rates at 60 minutes (92.9%, 89.3%, and 84.7% respectively) 2
  • However, higher loading doses (≥40 mg/kg) were associated with increased rates of intubation (45.8% vs 28.2% and 26.8% for medium and low doses) 2
  • Oral loading with 1500 mg has been shown to be well-tolerated with minimal side effects (11% reported mild transient symptoms) 4

Maintenance Dosing After Loading

  • For adults with partial onset seizures, maintenance dosing typically starts at 1000 mg/day (500 mg BID), which can be increased by 1000 mg/day every 2 weeks to a maximum of 3000 mg/day 5
  • After resolution of status epilepticus in children, maintenance doses of 15-30 mg/kg IV every 12 hours are recommended 1

Common Pitfalls and Caveats

  • Dosing should be adjusted for patients with renal impairment as levetiracetam is primarily eliminated by the kidneys 3
  • While higher loading doses (≥40 mg/kg) don't appear to improve efficacy, they may increase the risk of respiratory depression requiring intubation 2
  • When using oral loading in emergency situations, be aware that peak serum concentrations occur within 1-2 hours 4
  • The effectiveness of levetiracetam for status epilepticus varies, with studies showing efficacy rates between 38-89% 6

References

Guideline

Levetiracetam Loading Dose Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.